ATE84065T1 - Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. - Google Patents

Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Info

Publication number
ATE84065T1
ATE84065T1 AT87114733T AT87114733T ATE84065T1 AT E84065 T1 ATE84065 T1 AT E84065T1 AT 87114733 T AT87114733 T AT 87114733T AT 87114733 T AT87114733 T AT 87114733T AT E84065 T1 ATE84065 T1 AT E84065T1
Authority
AT
Austria
Prior art keywords
expression vector
igf
growth factor
human insulin
met
Prior art date
Application number
AT87114733T
Other languages
English (en)
Inventor
Ueda Ikuo
Niwa Mineo
Saito Yoshimasa
Ishii Yoshinori
Kitaguchi Tadashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE84065T1 publication Critical patent/ATE84065T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/35Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT87114733T 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. ATE84065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24070286 1986-10-09
EP87114733A EP0264074B1 (de) 1986-10-09 1987-10-08 Expressionsvektor für menschlichen insulinähnlichen Wachstumsfaktor-I

Publications (1)

Publication Number Publication Date
ATE84065T1 true ATE84065T1 (de) 1993-01-15

Family

ID=17063431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87114733T ATE84065T1 (de) 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Country Status (5)

Country Link
EP (1) EP0264074B1 (de)
AT (1) ATE84065T1 (de)
DE (1) DE3783305T2 (de)
ES (1) ES2044887T3 (de)
GR (1) GR3007491T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd hEGFの製法
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
WO1991018622A1 (en) * 1990-05-30 1991-12-12 President And Fellows Of Harvard College Wound healing
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
EP0440311A1 (de) * 1985-06-20 1991-08-07 Fujisawa Pharmaceutical Co., Ltd. Herstellungsverfahren für menschliches alpha-Atrio-natriuretisches Polypeptid

Also Published As

Publication number Publication date
EP0264074A2 (de) 1988-04-20
ES2044887T3 (es) 1994-01-16
DE3783305D1 (de) 1993-02-11
DE3783305T2 (de) 1993-05-19
EP0264074A3 (en) 1989-10-25
EP0264074B1 (de) 1992-12-30
GR3007491T3 (de) 1993-07-30

Similar Documents

Publication Publication Date Title
EP0156355A3 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
EP0244234A3 (en) Transformation of trichoderma
WO1989009787A3 (en) Osteogenic devices
DE69229572T2 (de) Gliazellen-aktivierender Faktor und dessen Herstellung
IT1223334B (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
ZA887773B (en) Interleukin-7
AU3329989A (en) Viper venom polypeptides and genetic expression
ATE84065T1 (de) Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
EP0643133A3 (de) Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung.
AU7151687A (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
NO175318C (no) Hybridgen for veksthormonfrigjörende faktor, replikerbar mikrobiell ekspresjonsvektor inneholdende et slikt gen, samt mikroorganisme transformert med en slik vektor og hybridpolypeptid som inneholder en Trp-GRF
ATE46537T1 (de) Promotor und dessen verwendung.
AU5309586A (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms
DK502786D0 (da) Fremgangsmaade til fremstilling af en vaekstfaktor
IT1202612B (it) Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
CA2080008A1 (en) Water-soluble mutein of fibroblast growth factor (fgf) receptor
DE69130818D1 (de) Chondromodulin-I-Protein
ES8801379A1 (es) Un metodo para preparar una secuencia de adn que codifica un polipeptido que tiene actividad de factor de crecimiento
IL82736A0 (en) Composite dna sequence,vectors,cells and bacterial strains comprising it and their use for the production of growth hormone
DE69121227T2 (de) Polypeptid

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee